Contribution of Interleukin-11 and Prostaglandin(s) in Lipopolysaccharide-Induced Bone Resorption In Vivo
暂无分享,去创建一个
D. Graves | S. Amar | L. Shapira | Li Li | A. Khansari
[1] T. Kawai,et al. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. , 2001, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[2] R. McIntyre,et al. Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[3] D. Graves,et al. Interleukin-1 and Tumor Necrosis Factor Activities Partially Account for Calvarial Bone Resorption Induced by Local Injection of Lipopolysaccharide , 1999, Infection and Immunity.
[4] N. Udagawa,et al. A novel molecular mechanism modulating osteoclast differentiation and function. , 1999, Bone.
[5] T. Martin,et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.
[6] U. Lerner,et al. Bone resorbing activity released from zymosan-activated mouse peritoneal macrophages - the role of prostanoids and interleukin-1 , 1999, Inflammation Research.
[7] K. Kornman. Host modulation as a therapeutic strategy in the treatment of periodontal disease. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] Ray Williams. Non-steroidal Anti-inflammatory Drugs for Altering Periodontal Bone Loss , 1999, Journal of dental research.
[9] T. Nishihara,et al. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. , 2010, Journal of periodontal research.
[10] A. Tumber,et al. The cellular actions of interleukin-11 on bone resorption in vitro. , 1998, Endocrinology.
[11] C. Ware,et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. , 1998, Journal of immunology.
[12] C. S. Lader,et al. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. , 1998, Endocrinology.
[13] J. Peschon,et al. Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors , 1997, The Journal of experimental medicine.
[14] P. Morrissey,et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. , 1997, Journal of immunology.
[15] R. Tapping,et al. Lipopolysaccharide dependent cellular activation. , 1997, Journal of periodontal research.
[16] S. Offenbacher. Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.
[17] Michael T. Wilson,et al. Bacterially induced bone destruction: mechanisms and misconceptions , 1996, Infection and immunity.
[18] N. Athanasou,et al. Cellular biology of bone-resorbing cells. , 1996, The Journal of bone and joint surgery. American volume.
[19] T. Martin,et al. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures , 1996, The Journal of experimental medicine.
[20] S. Akira,et al. Interleukin-6 family of cytokines and gp130. , 1995, Blood.
[21] S. Nair,et al. Lipid A-associated proteins from periodontopathogenic bacteria induce interleukin-6 production by human gingival fibroblasts and monocytes. , 1995, FEMS immunology and medical microbiology.
[22] J. Elias,et al. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. , 1995, Endocrinology.
[23] J. Guénet,et al. Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential. , 1994, Developmental biology.
[24] S. Dower,et al. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.
[25] G. Passeri,et al. Interleukin-11: a new cytokine critical for osteoclast development. , 1994, The Journal of clinical investigation.
[26] K. Tanamoto,et al. Induction of prostaglandin release from macrophages by bacterial endotoxin. , 1994, Methods in enzymology.
[27] R. Maier,et al. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. , 1993, The Journal of biological chemistry.
[28] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[29] M. Gayle,et al. Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Chambers,et al. Prostaglandin e2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] H. J. Sismey-Durrant,et al. Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1-beta release from rat periosteal and human gingival fibroblasts in vitro. , 1991, Oral microbiology and immunology.
[32] T. Chambers,et al. Effect of prostaglandins E1, E2, and F2α on osteoclast formation in mouse bone marrow cultures , 1991 .
[33] N. Udagawa,et al. Role of prostaglandins in interleukin‐1‐induced bone resorption in mice in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] T. Chambers,et al. Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures. , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] David A. Williams,et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Rodan,et al. Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. , 1990, Endocrinology.
[37] G. Mundy,et al. Effects of interleukin-1 on bone turnover in normal mice. , 1989, Endocrinology.
[38] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] S. Offenbacher,et al. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. , 1986, Journal of periodontal research.
[40] M Tuszkiewicz,et al. [Bacterial endotoxins]. , 1967, Polski tygodnik lekarski.